| Authors: |
Zou MF, Keck TM, Kumar V, Donthamsetti P; Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons , New York, New York 10027, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute , New York, New York 10032, United States., Michino M, Burzynski C, Schweppe C, Bonifazi A, Free RB; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health , 5625 Fishers Lane, Room 4S-04, Bethesda, Maryland 20892-9405, United States., Sibley DR; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health , 5625 Fishers Lane, Room 4S-04, Bethesda, Maryland 20892-9405, United States., Janowsky A; Research & Development Service, Veterans Affairs Portland Health Care System , Portland, Oregon 97239, United States.; Department of Psychiatry and Behavioral Neuroscience, School of Medicine and Methamphetamine Abuse Research Center, Oregon Health & Science University , Portland, Oregon 97239, United States., Shi L; Department of Physiology and Biophysics and the Institute for Computational Biomedicine, Weill Medical College of Cornell University , New York, New York 10065, United States., Javitch JA; Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons , New York, New York 10027, United States.; Division of Molecular Therapeutics, New York State Psychiatric Institute , New York, New York 10032, United States., Newman AH |
